421 related articles for article (PubMed ID: 3935706)
1. Branched chain amino acid therapy in liver disease.
Maddrey WC
J Am Coll Nutr; 1985; 4(6):639-50. PubMed ID: 3935706
[TBL] [Abstract][Full Text] [Related]
2. Infusion of branched-chain enriched amino acid solution in patients with hepatic encephalopathy.
Freund H; Dienstag J; Lehrich J; Yoshimura N; Bradford RR; Rosen H; Atamian S; Slemmer E; Holroyde J; Fischer JE
Ann Surg; 1982 Aug; 196(2):209-20. PubMed ID: 6284073
[TBL] [Abstract][Full Text] [Related]
3. Standard or branched-chain amino acid infusions as short-term nutritional support in liver cirrhosis?
Rocchi E; Cassanelli M; Gibertini P; Pietrangelo A; Casalgrandi G; Ventura E
JPEN J Parenter Enteral Nutr; 1985; 9(4):447-51. PubMed ID: 3928919
[TBL] [Abstract][Full Text] [Related]
4. Nutritional treatment with branched-chain amino acids in advanced liver cirrhosis.
Marchesini G; Bianchi G; Rossi B; Brizi M; Melchionda N
J Gastroenterol; 2000; 35 Suppl 12():7-12. PubMed ID: 10779207
[TBL] [Abstract][Full Text] [Related]
5. Is intravenous administration of branched chain amino acids effective in the treatment of hepatic encephalopathy? A multicenter study.
Wahren J; Denis J; Desurmont P; Eriksson LS; Escoffier JM; Gauthier AP; Hagenfeldt L; Michel H; Opolon P; Paris JC; Veyrac M
Hepatology; 1983; 3(4):475-80. PubMed ID: 6345330
[TBL] [Abstract][Full Text] [Related]
6. Late evening snacks with branched-chain amino acids improve the Fischer ratio with patients liver cirrhosis at fasting in the next morning.
Maki H; Yamanaka-Okumura H; Katayama T; Ozawa Y; Hosoda A; Kurata N; Amemiya F
Clin Nutr ESPEN; 2019 Apr; 30():138-144. PubMed ID: 30904214
[TBL] [Abstract][Full Text] [Related]
7. Branched-chain amino acid enriched supplements as therapy for liver disease.
Charlton M
J Nutr; 2006 Jan; 136(1 Suppl):295S-8S. PubMed ID: 16365102
[TBL] [Abstract][Full Text] [Related]
8. Branched-chain amino acids for people with hepatic encephalopathy.
Gluud LL; Dam G; Les I; Córdoba J; Marchesini G; Borre M; Aagaard NK; Vilstrup H
Cochrane Database Syst Rev; 2015 Feb; (2):CD001939. PubMed ID: 25715177
[TBL] [Abstract][Full Text] [Related]
9. Branched-chain amino acid supplementation in patients with liver diseases.
Marchesini G; Marzocchi R; Noia M; Bianchi G
J Nutr; 2005 Jun; 135(6 Suppl):1596S-601S. PubMed ID: 15930476
[TBL] [Abstract][Full Text] [Related]
10. Effects of oral branched-chain amino acids on hepatic encephalopathy and outcome in patients with liver cirrhosis.
Kawaguchi T; Taniguchi E; Sata M
Nutr Clin Pract; 2013 Oct; 28(5):580-8. PubMed ID: 23945292
[TBL] [Abstract][Full Text] [Related]
11. Long-term oral branched-chain amino acid treatment in chronic hepatic encephalopathy. A randomized double-blind casein-controlled trial. The Italian Multicenter Study Group.
Marchesini G; Dioguardi FS; Bianchi GP; Zoli M; Bellati G; Roffi L; Martines D; Abbiati R
J Hepatol; 1990 Jul; 11(1):92-101. PubMed ID: 2204661
[TBL] [Abstract][Full Text] [Related]
12. Effect of a high-protein, high-fiber diet plus supplementation with branched-chain amino acids on the nutritional status of patients with cirrhosis.
Ruiz-Margáin A; Macías-Rodríguez RU; Ríos-Torres SL; Román-Calleja BM; Méndez-Guerrero O; Rodríguez-Córdova P; Torre A
Rev Gastroenterol Mex (Engl Ed); 2018; 83(1):9-15. PubMed ID: 28408059
[TBL] [Abstract][Full Text] [Related]
13. Effect of a branched chain amino acid-enriched nutritional product on the pathophysiology of the liver and nutritional state of patients with liver cirrhosis.
Watanabe A; Shiota T; Okita M; Nagashima H
Acta Med Okayama; 1983 Aug; 37(4):321-33. PubMed ID: 6624532
[TBL] [Abstract][Full Text] [Related]
14. Branched-chain amino acids vs lactulose in the treatment of hepatic coma: a controlled study.
Rossi-Fanelli F; Riggio O; Cangiano C; Cascino A; De Conciliis D; Merli M; Stortoni M; Giunchi G
Dig Dis Sci; 1982 Oct; 27(10):929-35. PubMed ID: 6749458
[TBL] [Abstract][Full Text] [Related]
15. [Therapy of hepatic encephalopathy. Modification of the plasma aminogram using amino acid infusions].
Ferenci P; Funovics J; Wewalka F
Chir Forum Exp Klin Forsch; 1978; (1978):183-9. PubMed ID: 110563
[TBL] [Abstract][Full Text] [Related]
16. Negative nitrogen balance in cirrhotics. (A correct therapeutic approach).
Fiaccadori F; Ghinelli F; Pedretti G; Pelosi G; Sacchini D; Spadini G
Ric Clin Lab; 1981; 11(3):259-68. PubMed ID: 7291872
[TBL] [Abstract][Full Text] [Related]
17. Infusion of the branched chain amino acids in postoperative patients. Anticatabolic properties.
Freund H; Hoover HC; Atamian S; Fischer JE
Ann Surg; 1979 Jul; 190(1):18-23. PubMed ID: 464673
[TBL] [Abstract][Full Text] [Related]
18. Update on branched-chain amino acid supplementation in liver diseases.
Bianchi G; Marzocchi R; Agostini F; Marchesini G
Curr Opin Gastroenterol; 2005 Mar; 21(2):197-200. PubMed ID: 15711213
[TBL] [Abstract][Full Text] [Related]
19. Cirrhosis, encephalopathy, and improved results with metabolic support.
Cerra FB; McMillen M; Angelico R; Cline B; Lyons J; Faulkenbach L; Paysinger J
Surgery; 1983 Oct; 94(4):612-9. PubMed ID: 6623361
[TBL] [Abstract][Full Text] [Related]
20. The altered plasma amino acid pattern is responsible for the paradoxical growth hormone response to the oral glucose tolerance test in liver cirrhosis.
Martina V; Tagliabue M; Bruno GA; Bonetti G; Brancaleoni V; Meineri I; Saracco G; Zumpano E; Manieri C; Camanni F
Clin Endocrinol (Oxf); 1998 Feb; 48(2):175-80. PubMed ID: 9579229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
